Ketamine, a dissociative anesthetic, has carved itself a spot in the world of mental health care over the past two decades.
Bryan Johnson injected himself with ketamine, a hallucinogen favored by Elon Musk, for 15 days. He used a helmet from his ...
However, Johnson & Johnson has a 'savior' in its neuroscience portfolio, namely Spravato (esketamine), which is the NMDA receptor antagonist. Moreover, on January 21, 2025, the FDA approved ...
FDA's rejection of MDMA therapy for PTSD doesn't dampen hopes for other psychedelic treatments. Read more here.
The pharmaceutical company Johnson & Johnson created the spray from esketamine, a more potent version of ketamine. Esketamine should only provide rapid relief from depression symptoms until other ...
After the rejection of Lykos Therapeutics’ MDMA-based PTSD treatment tempered excitement for psychedelic therapeutics, a ...
Escalating concerns over impending tariffs and President Trump's foreign policies have fueled uncertainty and instability in ...
Spravato targets the neurotransmitter glutamate; however, the mechanism by which esketamine exerts its antidepressant ... Neuroscience, Johnson & Johnson Innovative Medicine, said in a statement.
“When Johnson & Johnson started researching Spravato ... scientific and medical communities about the difference between esketamine versus ketamine, and whether esketamine is as effective ...
Jan. 27, 2025 – After years of limited options, people with hard-to-treat depression finally have a new standalone treatment. The FDA’s latest approval of the nasal spray Spravato (esketamine ...
according to Johnson & Johnson. The main ingredient for the spray is esketamine hydrochloride, which is the “chemical cousin” of ketamine. Ketamine has been used by clinics across the U.S. to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results